Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-01)

NCT05478538 is registered in ClinicalTrials.gov with Elephas as lead sponsor.

NCT NCT05478538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05478538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-01)
Lead sponsor
Elephas
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2023
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic nsclc - non-small cell lung cancer, nsclc (non-small cell lung cancer)